Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/24/1992 | US5166155 Quinoxaline-2,3-dione compounds and their preparation and use |
11/24/1992 | US5166152 Immunostimulants, bactericides, viricides, antitumor agents |
11/24/1992 | US5166150 Cognition activators |
11/24/1992 | US5166149 Metal derivatives for skin disorders and hyperproliferative diseases |
11/24/1992 | US5166146 Amino acid cyclopentanophenonthrene compounds |
11/24/1992 | US5166145 Antinausea drug mixture of ondansetron and other chemicals |
11/24/1992 | US5166143 Angiotensin converting enzyme inhibitors such as phosphonate substituted amino acids, imino acids, phosphinylalkanoyl prolines or phosphonamidate |
11/24/1992 | US5166142 Use of type ia antiarrhythmic agents to lower blood lipids |
11/24/1992 | US5166141 Antigen specific immunune response by contacting lymphocytes |
11/24/1992 | US5166140 Use of certain nucleoside analogs to attenuate cancer cell resistance to DNA damaging chemotherapy |
11/24/1992 | US5166137 Guluronic acid polymers and use of same for inhibition of cytokine production |
11/24/1992 | US5166136 Antagonist of P undecapeptides as antiinflammatory agents and analgesics and for skin disorders |
11/24/1992 | US5165937 Controlled release tablets containing flavoxate |
11/24/1992 | CA2069455A1 Azole derivatives |
11/24/1992 | CA2069261A1 Pyrimidine derivatives, their preparation process, the new intermediates obtaines, their application as drugs and the pharmaceutical compositions containing them |
11/24/1992 | CA2068747A1 Heterocyclic compounds |
11/24/1992 | CA1310793C Nor-statine and nor-cyclostatine polypeptides |
11/24/1992 | CA1310792C N-heterocyclic alcohol renin inhibitors |
11/24/1992 | CA1310660C B, -dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound |
11/24/1992 | CA1310649C Process for the preparation of aryl-piperidine carbinols |
11/24/1992 | CA1310647C Heteroaryl 3-oxo-propanenitrile derivatives and process for their preparation |
11/24/1992 | CA1310646C Antiarrhythmic agents |
11/24/1992 | CA1310642C 2-amino-5-hydroxy-4-pyrimidones |
11/24/1992 | CA1310638C Imidazo-benzodiazepines and their use in the treatment of memory or cerebral senescence disorders |
11/24/1992 | CA1310637C Epipodophyllotoxin glucoside 4'-phosphate derivatives |
11/24/1992 | CA1310631C 17.alpha.-HALOGEN-VINYLE-STRANES |
11/24/1992 | CA1310585C COSMETIC APPLICATION OF POLYSILOXANES HAVING A .beta.-CETOESTER FUNCTION, AND COMPOSITIONS PRODUCED |
11/24/1992 | CA1310583C Polymeric carrier compositions and methods for their preparation and use |
11/24/1992 | CA1310582C Agents against protozoa in insects |
11/23/1992 | WO1992020676A1 Substituted 3-aminoquinuclidines |
11/23/1992 | WO1992020346A1 Method and composition to reduce myocardial reperfusion injury |
11/22/1992 | CA2103464A1 Backbone modified oligonucleotide analogs |
11/22/1992 | CA2068918A1 Formulations useful for the inhibition of massive release of cerebral glutamate |
11/21/1992 | WO1992020699A1 Steroid compound combined with polysaccharide |
11/21/1992 | CA2087452A1 Steriod compound combined with polysaccharide |
11/21/1992 | CA2068980A1 Diltiazem formulation |
11/21/1992 | CA2068951A1 Process for the preparation of 8a-aza-8a-homoerythromycin cyclic lactams |
11/21/1992 | CA2068567A1 Amide esters of rapamycin |
11/19/1992 | EP0514367A2 Protein C-containing drug |
11/19/1992 | EP0514361A1 Galanin antagonist |
11/19/1992 | EP0514357A1 Use of esters of acyl L-carnitines with gamma-hydroxybutyric acid for producing pharmaceutical compositions for the treatment of hepatopathies |
11/19/1992 | EP0514328A1 Chenodeoxycholic acid or ursodeoxycholic acid for the treatment of diseases of the respiratory organs |
11/19/1992 | EP0514277A1 3-Aminopyridazine derivatives active on the central nervous system |
11/19/1992 | EP0514276A1 Thiopyranopyrrole derivatives and their preparation |
11/19/1992 | EP0514275A1 Thiopyranopyrrole derivatives, their preparation and pharmaceutical compositions containing them |
11/19/1992 | EP0514273A1 New derivatives of perhydroisoindole, their preparation and pharmaceutical compositions containing them |
11/19/1992 | EP0514269A1 Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics |
11/19/1992 | EP0514268A1 Substituted amino acid azetidinyl pyridone derivatives, their preparation and use as medicines |
11/19/1992 | EP0514267A1 Amide derivatives of 1-amino-octahydropyrido[2,1-c][1,4]oxazine, processes for their preparation and pharmaceutical compositions containing them |
11/19/1992 | EP0514264A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics |
11/19/1992 | EP0514217A1 Antihypertensive benzofuran derivatives carrying 4-pyrazolylmethyl substituents |
11/19/1992 | EP0514216A1 Antihypotensive benzofuran derivatives with N-linked 1H-imidazolyl-methyl-5-carboxamide substituents |
11/19/1992 | EP0514198A1 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group |
11/19/1992 | EP0514197A1 Anti-hypertensive benzofuran derivatives substituted by N-imidazolyl-methyl groups which are condensed with optionally nitrogen containing, six-membered rings |
11/19/1992 | EP0514193A1 N-linked imidazolyl-methyl benzofuran derivatives with antihypotensive activity |
11/19/1992 | EP0514192A1 Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups |
11/19/1992 | EP0514144A2 Rapamycin metabolites |
11/19/1992 | EP0514133A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
11/19/1992 | EP0514131A1 2-benzazepines with 5-and 6-membered heterocyclic rings |
11/19/1992 | EP0514126A1 Benzodiazepine analogs |
11/19/1992 | EP0514125A1 Triazolobenzodiazepines |
11/19/1992 | EP0514124A2 Use of phosphonomethylphosphinate squalene synthetase inhibitors for the manufacture of a medicament for the lowering cholesterol |
11/19/1992 | EP0514090A1 Procedure for the inversion of the stereochemistry at C13 of avermectin aglycone compounds |
11/19/1992 | EP0514056A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry |
11/19/1992 | EP0514036A2 Preparation of thionucleosides |
11/19/1992 | EP0514023A1 Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal |
11/19/1992 | EP0514015A1 Control of sex differentiation in fish |
11/19/1992 | EP0514009A1 Corneal treatment agents |
11/19/1992 | EP0514008A1 Pharmaceutical preparations based on gastrointestinal mucosa-adherent matrixes or coatings |
11/19/1992 | EP0513997A1 Antithrombotic compositions |
11/19/1992 | EP0513979A1 Angiotensin II antagonists incorporating a substituted thiophene or furan |
11/19/1992 | EP0513974A1 Novel benzo-fused lactams that promote the release of growth hormone |
11/19/1992 | EP0513947A1 14 Alpha, 16alpha-ethano- and 14alpha, 16alpha ethenoestratrienes |
11/19/1992 | EP0513917A1 Antiviral combinations containing nucleoside analogs |
11/19/1992 | EP0513887A1 N-alkyltauroursodeoxycholic acids and their therapeutically active derivatives, a process for their preparation and pharmaceutical compositions containing them |
11/19/1992 | EP0513878A2 Pharmaceutical compositions containing cationic surfactants |
11/19/1992 | EP0513862A2 Use of topical applicable preparation for treating skin aging |
11/19/1992 | EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
11/19/1992 | EP0513783A2 Method for the removal of contaminants from perfluorinated alkyl bromides or alkylene dibromides |
11/19/1992 | EP0513761A2 Bisphosphonate squalene synthetase inhibitors |
11/19/1992 | EP0513760A2 Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol |
11/19/1992 | EP0513702A2 Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication |
11/19/1992 | EP0513691A1 Anti-ulcer agent |
11/19/1992 | EP0513671A1 Commiphora mukul extracts and therapeutical applications thereof |
11/19/1992 | EP0513533A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application |
11/19/1992 | EP0513434A1 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/acetylsalicylic acid (DISALAZINE) |
11/19/1992 | EP0513400A1 Use of 2-ethoxy benzoic acid for the manufacture of a medicament as analgesic, antipyretic, and/or antiphlogistic |
11/19/1992 | EP0513387A1 Active oxygen inhibitor |
11/19/1992 | EP0513379A1 2-arylthiazole derivative and pharmaceutical composition containing the same |
11/19/1992 | EP0513351A1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient |
11/19/1992 | EP0513345A1 Therapeutic and diagnostic applications of fetal fibronectin |
11/19/1992 | EP0513200A1 Method and compositions for the synthesis of bch-189 and related compounds |
11/19/1992 | EP0513177A1 5-oxygenated-2,4,6-triaminopyrimidines |
11/19/1992 | EP0513127A1 Propellant compositions. |
11/19/1992 | EP0513104A1 USE OF AN -g(a)-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED. |
11/19/1992 | EP0513099A1 Novel vehicle gases and their use in medical preparations |
11/19/1992 | EP0513058A1 Use of known uraciles for the manufacture of a medicament for the protection from and treatment of diseases involving proliferative processes. |
11/19/1992 | EP0513016A1 Cycloalkyl-substituted glutaramide diuretic agents |
11/19/1992 | EP0471057A4 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections |
11/19/1992 | EP0249620B1 Process for the preparation of quinoline carboxylic acids |